Application Information

This drug has been submitted to the FDA under the reference 205811/001.

Names and composition

"DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE" is the commercial name of a drug composed of DOXYLAMINE SUCCINATE and PYRIDOXINE HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
205811/001 DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE TABLET, DELAYED RELEASE/ORAL 10MG and 10MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
010598/002 BENDECTIN DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 10MG and 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
021876/001 DICLEGIS DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE TABLET, DELAYED RELEASE/ORAL 10MG and 10MG
205811/001 DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE TABLET, DELAYED RELEASE/ORAL 10MG and 10MG
209661/001 BONJESTA DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 20MG and 20MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved